BioSpace News Archive

Business

The Cooper Companies Announces Fourth Quarter and Full Year 2017 Results

Fourth quarter revenue increased 8% year-over-year to $561.5 million. Fiscal 2017 revenue increased 9% to $2,139.0 million.

December 8, 2017
·
22 min read
BioCapital

QIAGEN to Transfer U.S. Listing of Global Shares to NYSE

QIAGEN N.V. today announced that it is transferring the U.S. listing of its global shares to the NYSE from the NASDAQ Global Market.

December 8, 2017
·
1 min read
Drug Development

Trovagene Presents Data Showing Sensitivity of Triple Negative Breast Cancer (TNBC) Cell Lines to PCM-075 and Synergy with Zytiga® at San Antonio Breast Cancer Symposium (SABCS)

The presentation data indicates that PCM-075 in combination with anti-androgen, abiraterone acetate are synergistic in inducing cell death within an AR+ TNBC cell line.

December 8, 2017
·
6 min read
Deals

SoCal’s Hancock Jaffe Laboratories Files for $20M IPO

The firm is developing life-enhancing bioprosthetic devices and technologies for patients with debilitating cardiovascular diseases.

December 8, 2017
·
1 min read
Policy

SteadyMed Announces FDA Agreed Pathway to Trevyent NDA Resubmission

No clinical trials are required for the NDA resubmission.

December 8, 2017
·
4 min read
Business

Prime Therapeutics Signs Outcomes-Based Contract With Novo Nordisk for Type 2 Diabetes Drug Victoza (liraglutide)

This new contract with Novo Nordisk for Victoza aligns to Prime’s strategy by focusing on controlling overall costs for members.

December 8, 2017
·
3 min read
Policy

Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

At the meeting, the panel voted 15 to 0 that patients with interstitial cystitis and patients with bladder pain syndrome should be combined in clinical trials.

December 8, 2017
·
6 min read
Biotech Beach

Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock

The quarterly dividend on the Series E Preferred Stock is payable on January 2, 2018 to holders of record at the close of business on December 18, 2017

December 8, 2017
·
2 min read